SCHEMBL8302681

SCHEMBL8302681

Brc1c(NC2NCCN2)ccc2cn[nH]c12

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ NOS1 P29475 3/20 0.39
▸ MAPT P10636 2/20 0.34
▸ SYK P43405 1/20 0.33
▸ GLA P06280 1/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.33
▸ METAP2 P50579 1/20 0.33
▸ DYRK1A Q13627 1/20 0.33
▸ ALDH1A1 P00352 2/20 0.31
▸ KDM4E B2RXH2 1/20 0.31
▸ MEN1 O00255 1/20 0.31
▸ APAF1 O14727 1/20 0.31
▸ MAPK1 P28482 1/20 0.31
▸ BLM P54132 1/20 0.31
▸ KMT2A Q03164 1/20 0.31
▸ HSD17B10 Q99714 1/20 0.31
▸ TDP1 Q9NUW8 1/20 0.31
▸ HTT P42858 1/20 0.31
▸ IDO1 P14902 1/20 0.31
▸ TDO2 P48775 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6968276 0.82 MAPT (0.41) NOS1MAPTSYKGLAL3MBTL1
Hydrochloric Acid SCHEMBL6977242 0.81 MAPT (0.40) NOS1MAPTSYKGLAL3MBTL1
SCHEMBL6964834 0.79 MAPT (0.35) NOS1MAPTSYKGLAL3MBTL1
SCHEMBL3658627 0.79 GLA (0.50) NOS1MAPTGLAL3MBTL1KDM4E
SCHEMBL11988457 0.74 NOS1 (0.46) NOS1MAPTGLAL3MBTL1METAP2
SCHEMBL8302677 0.70 ADRA2A (0.58) MAPTALDH1A1KDM4EMAPK1BLM
SCHEMBL8302685 0.68 NOS1 (0.36) NOS1MAPTSYKGLAL3MBTL1
SCHEMBL3661475 0.67 ALDH1A1 (0.62) NOS1MAPTMETAP2DYRK1AALDH1A1
SCHEMBL564135 0.66 ADRA2A (0.55) MAPTALDH1A1KDM4EMEN1MAPK1
SCHEMBL20237898 0.65 NOS1 (0.50) NOS1MAPTGLAL3MBTL1METAP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0944620-A1 2-IMIDAZOLINYLAMINOINDAZOLE COMPOUNDS USEFUL AS ALPHA-2 ADRENOCEPTOR AGONISTS THE PROCTER & GAMBLE COMPANY (US) 1999-09-29 — — EP claimed
WO-1998023609-A1 2-IMIDAZOLINYLAMINOINDAZOLE COMPOUNDS USEFUL AS ALPHA-2 ADRENOCEPTOR AGONISTS THE PROCTER & GAMBLE COMPANY (US) 1998-06-04 — — WO claimed
CN-1244864-A 2-imidazolinylaminoindazole compounds useful as alpha-2 adrenoceptor agonists PROCTER & GAMBLE (US) 2000-02-16 — — CN disclosed
EP-0944620-A1 2-IMIDAZOLINYLAMINOINDAZOLE COMPOUNDS USEFUL AS ALPHA-2 ADRENOCEPTOR AGONISTS THE PROCTER & GAMBLE COMPANY (US) 1999-09-29 — — EP disclosed
EP-0944620-A1 2-IMIDAZOLINYLAMINOINDAZOLE COMPOUNDS USEFUL AS ALPHA-2 ADRENOCEPTOR AGONISTS THE PROCTER & GAMBLE COMPANY (US) 1999-09-29 — — EP disclosed
WO-1998023609-A1 2-IMIDAZOLINYLAMINOINDAZOLE COMPOUNDS USEFUL AS ALPHA-2 ADRENOCEPTOR AGONISTS THE PROCTER & GAMBLE COMPANY (US) 1998-06-04 — — WO disclosed
WO-1998023609-A1 2-IMIDAZOLINYLAMINOINDAZOLE COMPOUNDS USEFUL AS ALPHA-2 ADRENOCEPTOR AGONISTS THE PROCTER & GAMBLE COMPANY (US) 1998-06-04 — — WO disclosed
Send feedback